切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2024, Vol. 18 ›› Issue (04) : 253 -257. doi: 10.3877/cma.j.issn.1674-0793.2024.04.002

述评

腹腔镜胰十二指肠切除术应用现状及展望
真婷婷1, 王敏1, 秦仁义1,()   
  1. 1. 430030 武汉,华中科技大学同济医学院附属同济医院胆胰外科
  • 收稿日期:2024-05-15 出版日期:2024-08-01
  • 通信作者: 秦仁义
  • 基金资助:
    国家自然科学基金资助项目(82273442)

Current status and outlook of laparoscopic pancreaticoduodenectomy

Tingting Zhen, Min Wang, Renyi Qin()   

  • Received:2024-05-15 Published:2024-08-01
  • Corresponding author: Renyi Qin
引用本文:

真婷婷, 王敏, 秦仁义. 腹腔镜胰十二指肠切除术应用现状及展望[J]. 中华普通外科学文献(电子版), 2024, 18(04): 253-257.

Tingting Zhen, Min Wang, Renyi Qin. Current status and outlook of laparoscopic pancreaticoduodenectomy[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(04): 253-257.

胰十二指肠切除术需要对胰腺周围关键的结构进行精细解剖及消化道重建,是胰腺外科最复杂的术式之一。1994年Gagner等[1]报道了世界首例腹腔镜胰十二指肠切除术(laparoscopic pancreaticoduodenectomy, LPD),此后随着腹腔镜设备的改善和技术的提升,LPD在全世界大型胰腺外科中心逐渐开展。尽管LPD开展的例数较前增多,但是其学习曲线以及术后疗效尚未得到一致的认可。本文通过对其现有研究的回顾,探讨现阶段LPD术式及学习曲线的研究进展,术后疗效分析及未来的研究趋势。

[1]
Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy[J]. Surg Endosc, 1994, 8(5): 408-410.
[2]
华杰, 王巍. 腹腔镜胰十二指肠切除术手术入路选择及评价[J].中国实用外科杂志, 2022, 42(05): 513-518.
[3]
Pessaux P, Regenet N, Arnaud JP. Resection of the retroportal pancreatic lamina during a cephalic pancr eaticoduodenectomy: first dissection of the superior mesenteric artery[J]. Ann Chir, 2003, 128(9): 633-636.
[4]
秦仁义, 马春阳, 朱峰, 等. 动脉入路在腹腔镜胰十二指肠切除术中的运用[J].中华消化外科杂志, 2017, 16(8): 6.
[5]
谭志健, 沈展涛, 刘一峰. No-touch技术在胰头癌腹腔镜胰十二指肠切除术中的初步效果[J]. 中华肝胆外科杂志, 2020, 26(8): 624.
[6]
Lin R, Lin X, Lu F, et al. Combination of anterior superior mesenteric vein-first and right posterior superior mesenteric artery-first approaches for uncinate process dissection in minimally invasive pancreaticoduodenectomy[J]. Gland Surg, 2020, 9(5): 1396-1405.
[7]
洪德飞, 刘亚辉, 张宇华. 腹腔镜胰十二指肠切除术中洪氏一针法胰管空肠吻合的临床应用[J]. 中华外科杂志, 2017, 55(2): 136-140.
[8]
陈孝平. 贯穿胰腺纵向"U"形缝合法行空肠内翻套入式胰肠吻合术[J]. 腹部外科, 2017, 30(3): 153-154.
[9]
Oda T, Hashimoto S, Miyamoto R, et al. The tight adaptation at pancreatic anastomosis without parenchymal laceration: An institutional experience in introducing and modifying the new procedure[J]. World J Surg, 2015, 39(8): 2014-2022.
[10]
Wang M, Xu S, Zhang H, et al. Imbedding pancreaticojejunostomy used in pure laparoscopic pancreaticoduodenectomy for nondilated pancreatic duct[J]. Surg Endosc, 2017, 31(4): 1986-1992.
[11]
中华医学会外科学分会. 腹腔镜胰腺外科手术缝合技术与缝合材料选择中国专家共识(2021版)[J]. 中国实用外科杂志, 2021, 41(5): 489-494.
[12]
van Hilst J, de Rooij T, Bosscha K, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): A multicentre, patient-blinded, randomised controlled phase 2/3 trial[J]. Lancet Gastroenterol Hepatol, 2019, 4(3): 199-207.
[13]
Nagakawa Y, Nakamura Y, Honda G, et al. Learning curve and surgical factors influencing the surgical outcomes during the initial experience with laparoscopic pancreaticoduodenectomy[J]. J Hepatobiliary Pancreat Sci, 2018, 25(11): 498-507.
[14]
Wang M, Peng B, Liu J, et al. Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China: A retrospective multicenter analysis of 1 029 patients[J]. Ann Surg, 2021, 273(1): 145-153.
[15]
Wang M, Li D, Chen R, et al. Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: A multicentre, open-label, randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2021, 6(6): 438-447.
[16]
彭丰, 王敏, 谢昱, 等. 腹腔镜胰十二指肠切除术学习曲线不同阶段的近期疗效研究[J]. 中华外科杂志, 2021, 71(7): 618-623.
[17]
Feng Q, Xin Z, Qiu J, et al. Laparoscopic vs. open pancreaticoduodenectomy after learning curve: A systematic review and meta-analysis of single-center studies[J]. Front Surg, 2021, 8: 715083.
[18]
Croome KP, Farnell MB, Que FG, et al. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?[J]. Ann Surg, 2014, 260(4): 633-638.
[19]
Jiang YL, Zhang RC, Zhou YC. Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis[J]. BMC Cancer, 2019, 19(1): 781.
[20]
Qin T, Zhang H, Pan S, et al. Effect of laparoscopic and open pancreaticoduodenectomy for pancreatic or periampullary tumors: three-year follow-up of a randomized clinical trial[J]. Ann Surg, 2024, 279(4): 605-612.
[21]
Asbun HJ, Stauffer JA. Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the accordion severity grading system[J]. J AM Coll Surg, 2012, 215(6): 810-819.
[22]
Daly MB, Pal T, Berry MP, et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2021, 19(1): 77-102.
[23]
Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial[J]. Lancet, 2017, 389(10073): 1011-1024.
[24]
Gueli Alletti S, Vizzielli G, Lafuenti L, et al. Single-institution propensity-matched study to evaluate the psychological effect of minimally invasive interval debulking surgery versus standard laparotomic treatment: from body to mind and back[J]. J Minim Invasive Gynecol, 2018, 25(5): 816-822.
[25]
van Dijk SM, Heerkens HD, Tseng DSJ, et al. Systematic review on the impact of pancreatoduodenectomy on quality of life in patients with pancreatic cancer[J]. HPB (Oxford), 2018, 20(3): 204-215.
[26]
Langan RC, Graham JA, Chin AB, et al. Laparoscopic-assisted versus open pancreaticoduodenectomy: early favorable physical quality-of-life measures[J]. Surgery, 2014, 156(2): 379-384.
[27]
Roland CL, Yang AD, Katz MH, et al. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer[J]. Ann Surg Oncol, 2015, 22(4): 1168-1175.
[28]
卓奇峰, 刘梦奇, 李征, 等. 胰腺癌新辅助化疗后腹腔镜手术治疗的效果分析[J]. 中华外科杂志, 2022, 60(2): 134-139.
[29]
Mora-Oliver I, Garcés-Albir M, Dorcaratto D, et al. Pancreatoduodenectomy with artery-first approach[J]. Minerva Chir, 2019, 74(3): 226-236.
[30]
Wang X, Luo Q, Li S, et al. A comparative study of the "superior mesenteric artery first" approach versus the conventional approach in short-term and long-term outcomes in patients with pancreatic ductal adenocarcinoma undergoing laparoscopic pancreaticoduodenectomy[J]. Surg Endosc, 2023, 37(12): 9326-9338.
[31]
任芳, 金巍巍, 鲁超, 等. Easy First策略行腹腔镜胰十二指肠切除术治疗可能切除胰腺癌的临床疗效[J]. 中华消化外科杂志, 2015, 14(8): 644-647.
[32]
李庆斌, 李光兵, 李飞宇, 等. 腹腔镜胰十二指肠切除术中胰肠吻合术式分析[J]. 中华肝胆外科杂志, 2023, 29(2): 155-160.
[33]
Torphy RJ, Friedman C, Halpern A, et al. Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers[J]. Ann Surg, 2019, 270(6): 1147-1155.
[34]
de Rooij T, van Hilst J, Topal B, et al. Outcomes of a multicenter training program in laparoscopic pancreatoduodenectomy (LAELAPS-2)[J]. Ann Surg, 2019, 269(2): 344-350.
[35]
中华医学会外科学分会, 中华医学会麻醉学分会. 加速康复外科中国专家共识暨路径管理指南(2018):胰十二指肠切除术部分[J]. 中华麻醉学杂志, 2018, 38(1): 19-23.
[36]
中华医学会外科学分会, 中华医学会麻醉学分会. 中国加速康复外科临床实践指南(2021)(一)[J]. 协和医学杂志, 2021, 12(5): 624.
[37]
Liao R, Li JC, Chen J, et al. A clinical observational study on the application of enhanced recovery after laparoscopic pancreaticoduodenectomy[J]. Front Surg, 2022, 9: 961161.
[38]
Gleeson EM, Clarke JR, Morano WF, et al. Patient-specific predictors of failure to rescue after pancreaticoduodenectomy[J]. HPB (Oxford), 2019, 21(3): 283-290.
[39]
GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery. Effects of hospital facilities on patient outcomes after cancer surgery: An international, prospective, observational study[J]. Lancet Glob Health, 2022, 10(7): e1003-e1011.
[40]
Hartwig W, Werner J, Jager D, et al. Improvement of surgical results for pancreatic cancer[J]. Lancet Oncol, 2013, 14(11): e476-e485.
[41]
Li Z, Zhuo Q, Li B, et al. Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: A retrospective cohort study[J]. World J Surg Oncol, 2024, 22(1): 1.
No related articles found!
阅读次数
全文


摘要